SG-210 (SPR 210) is an orally active and selective aldose reductase ( AR ) inhibitor. SG-210 has IC 50 values of 9.5 nM and 10 nM for AR from porcine lens and human placenta, respectively. SG-210 can inhibit sorbitol accumulation and ameliorate diabetic neuropathy and retinopathy in Streptozotocin ( HY-13753 )-induced diabetic rats. SG-210 can be used in the research of diseases such as diabetes-related complications.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Aldose Reductase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.